Protagonist Therapeutics, Inc Other Comprehensive Income (Loss), Net of Tax
Protagonist Therapeutics, Inc (PTGX) reported Other Comprehensive Income (Loss), Net of Tax of -$143.00 thousand for the 12-month period ending 2016-12-31, per its 10-K filed 2017-03-07.
Discontinued › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossNetOfTax · last filed 2017-03-07
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax for fiscal 2016 was -$143.00K.
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax for fiscal 2015 was -$2.00K.
- Protagonist Therapeutics, Inc other comprehensive income (loss), net of tax for fiscal 2014 was -$54.00K.
| Period end | Other Comprehensive Income (Loss), Net of Tax 12 month |
|---|---|
| 2016-12-31 | -$143.00K 10-K · filed 2017-03-07 |
| 2015-12-31 | -$2.00K 10-K · filed 2017-03-07 |
| 2014-12-31 | -$54.00K 10-K · filed 2017-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |
| ARROWHEAD PHARMACEUTICALS, INC. (ARWR) | United States | $9.331B | -42.28 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Axsome Therapeutics, Inc. (AXSM) | United States | $10.274B | -66.82 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |